Genomic Testing Market Megatrends 2026: Assessing Strategic Priorities for the Journey to 2030

Author : kumar shrey | Published On : 12 Aug 2026

Astute Analytica is recognized as a leading provider of comprehensive market research reports specifically designed for the Genomic Testing Market sector. Our reports are characterized by their in-depth market forecasts, detailed analyses of industry trends, competitive benchmarks, and assessments of future growth opportunities. As the healthcare sector undergoes transformative changes, driven by technological advancements, evolving patient needs, and a growing emphasis on sustainability, our insights are crucial for stakeholders aiming to navigate this complex landscape. The current focus is on shifting care from traditional hospital settings to patients' homes, enhancing quality of life while minimizing disruptions.

Explore Our Free-Market Analysis Sample – Instant Access: -https://www.astuteanalytica.com/request-sample/genomic-testing-market

Genomic testing market was valued at USD 16.62 billion in 2025 and is projected to attain a valuation of USD 41.34 billion by 2035, at a CAGR of 9.54% during the forecast period, 2026-2035.

Key Findings Shaping the Market

• Based on product type, reagents and consumables segment accounts for over 46.7% of the market share.
• Based on testing type, sequencing solutions, more predominantly Next Generation Sequencing (NGS) technologies, remain the huge players in the genomic testing market accounting for a market share exceeding 66.73%.
• Based on application, drug development and drug discovery emerged as the key consumers of the genomic testing around the world with more than 46% global market revenue comes from this application.
• By technique, all stem cell therapy remains an important aspect of market, and it occupied 42.4% share.
• North America is leader in the global genomic testing market by accounting for 35% market share.

How Are Chronic Disease Epidemics Fueling the Surge in Demand?

Chronic diseases are the primary engine propelling the genomic testing market forward. According to the World Health Organization (WHO) 2024 updates, cancer remains a leading cause of death, with approximately 20 million new cases reported annually worldwide. The WHO further projects a 77% increase in cancer cases by 2050. Consequently, the demand for genomic profiling in oncology has skyrocketed, as oncologists rely on these tests to identify specific Cancer biomarkers for targeted therapies. In the United States alone, the Centers for Disease Control and Prevention (CDC) reported in 2024 that over 38.4 million Americans have diabetes, and another 97.6 million have prediabetes. As research increasingly links specific genetic markers to Type 2 diabetes susceptibility, genomics testing is becoming a vital tool for early intervention and lifestyle modification strategies.

Precision medicine is the direct beneficiary of these alarming statistics. For instance, the survival rate for patients treated with genomically matched therapies is significantly higher than those receiving standard chemotherapy. In 2025, Natera reported a massive 52% year-over-year increase in their oncology test volumes, processing 800,800 tests. Such figures indicate that the clinical community is aggressively adopting genomics testing to manage the burden of chronic disease. Guardant Health similarly saw its biopharmaceutical test volumes grow by 56% in Q2 2024, proving that drug developers are equally reliant on genomic data to create next-generation treatments for these conditions.

Which Technology Reigns Supreme in the Genomics Landscape?

Next-Generation Sequencing (NGS) stands as the undisputed titan of the genomic testing market. Unlike older methods like Sanger sequencing or microarrays, NGS offers high-throughput capabilities that allow for the simultaneous sequencing of millions of DNA strands. The demand for NGS is growing exponentially in cancer gene therapy because it delivers speed, accuracy, and unprecedented cost-efficiency. In 2024, Illumina claimed its NovaSeq X series reduced the cost of sequencing a human genome to approximately USD 200. This price point breaks the economic barrier that previously prevented widespread adoption, making whole-genome sequencing (WGS) feasible for routine clinical care rather than just elite research.

Innovation in read lengths is further solidifying NGS dominance in the genomic testing market. PacBio, a leader in long-read sequencing, achieved a read length record of over 4 million base pairs in 2024/2025 research studies. Long-reads are essential for detecting structural variants that short-read technologies often miss. In fact, PacBio reported a 16.7% improvement in solving previously undiagnosed neurodegenerative cases in 2025 using their technology. Such technological leaps ensure that NGS remains the preferred platform for the genomics testing industry, driving a hardware replacement cycle that benefits manufacturers.

Download the Full Market Sample Report – Get Actionable Insights Now

Top Companies in Global Genomic Testing Market:

• Agilent Technologies, Inc.
• BGI Group
• Bio-Rad Laboratories
• Danaher Corporation
• Eurofins Genomics
• F. Hoffmann-La Roche
• Illumina, Inc.
• QIAGEN
• Singular Genomics Systems, Inc.
• Thermo Fisher Scientific, Inc.
• Other Prominent players

Market Segmentation Overview:

By Offering:

• System and Software
• Reagents & Consumables
• Services
  • DTC Genomic Testing Service
  • Sale of genomic data

By Testing Type:

• Sequencing Solution
  • DNA Sequencing
  • RNA Sequencing
  • Methylation Sequencing
  • NGS Library Preparation
  • Sequencing Data Analysis
• Others
  • Microarray Solution
  • Human Genotyping with Arrays
  • Non-Human Genotyping with Arrays
  • Methylation Array Analysis
  • Microarray Data Analysis
  • Others

By Technology:

• Proteomics
• Pharmacogenomics
• Stem Cell Therapy
• Cloning

By Indication:

• Cancer
• Asthma
• Diabetes
• Hearth Diseases
• Other Indication

By Application:

• Drug Discovery & Development
• Disease Diagnosis
• Agricultural Production
• Others

By End-User:

• Hospitals & Clinics
• Research Centers & Academic Institutions
• Pharmaceutical & Biotechnology Companies
• Others

By Region:

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
• Asia Pacific
  • Malaysia
  • Thailand
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
• South America
  • Argentina
  • Brazil
  • Rest of South America

Key Trends Shaping the Future of Healthcare

As we look to the future, ten key trends are emerging that will shape the healthcare landscape over the next decade. These include: an increase in the number of patients, greater reliance on technology, an abundance of information, the patient as the ultimate consumer, the development of new delivery models, innovation driven by competition, rising costs, an increasing number of uninsured individuals, reduced payments for providers, and the ongoing need for a reformed healthcare system. These trends highlight the necessity for healthcare organizations to adapt and innovate continuously to meet the evolving demands of the market.

𝐓𝐚𝐤𝐞 𝐚 𝐅𝐢𝐫𝐬𝐭 𝐋𝐨𝐨𝐤 𝐈𝐧𝐬𝐢𝐝𝐞: 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐅𝐢𝐥𝐞: -https://www.astuteanalytica.com/request-sample/genomic-testing-market

About Astute Analytica:

Astute Analytica is a leading market research and consulting firm committed to providing organizations with actionable insights and data-driven strategies to thrive in dynamic markets. With a strong presence in both global and regional markets, we publish extensive industry reports, conduct targeted surveys, and offer custom consulting services tailored to meet specific client needs. Our expertise spans multiple sectors, including technology, healthcare, chemicals, manufacturing, energy, and more, making us a valuable partner for forward-thinking businesses.

Get in touch with us

Phone number: +18884296757

Email: [email protected]

Visit our website: https://www.astuteanalytica.com/

LinkedIn | Twitter | YouTube | Facebook | Pinterest